project id: TCGA-BRCA; case submitter id: TCGA-B6-A0IN; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 8.0; spectrophotometer method: UV Spec; age at index: 45; days to birth: -16705; days to death: 2573; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1951; year of death: 2003; age at diagnosis: 16705; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage X; ajcc pathologic t: T1c; ajcc staging system edition: 4th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8523/3; primary diagnosis: Infiltrating duct mixed with other types of carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 1996; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 5073; days to sample procurement: 0; initial weight: 20.0; portion submitter id: TCGA-B6-A0IN-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;